Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500114091Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in Cardiovascular collapse and perioperative hypotension (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Cardiac Index (CI) and Systemic Vascular Resistance (SVR). Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500114091.